Evidence map›Paper›PMID 24178899›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2013

Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC).

Charles A McKay

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Group-I lead oxide XRSC advances · 2025
    Article
  4. The effect of chelation on bone Pb stores in Pb poisoned children.Journal of exposure science & environmental epidemiology · 2025
    Article
  5. Article
  6. Blood Lead Levels, Hemoglobin, and Liver Enzymes in Opium-Dependent Addicts.International journal of preventive medicine · 2021
    Article
  7. (Ascorb)ing Pb Neurotoxicity in the Developing Brain.Antioxidants (Basel, Switzerland) · 2020
    Review
  8. Article
  9. Evaluation and management of lead exposure.Annals of occupational and environmental medicine · 2015
    Review
  10. Current use of chelation in American health care.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2013
    Review
  11. Medical toxicology case presentations: to chelate or not to chelate, is that the question?Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Charles A McKayDivision of Medical Toxicology, Department of Emergency Medicine, Hartford Hospital/University of Connecticut School of Medicine, American College of Medical Toxicology, 10645 N. Tatum Blvd. Suite 200-111, Phoenix, AZ, 85028, USA, Charles.McKay@hhchealth.org.
University of Connecticut · US

Funding

ENVIRONMENTAL HEALTH AND TOXICOLOGY: PROFESSIONAL EDUCATION AND PUBLIC HEALTH CONU61TS000117 · TS · AMERICAN COLLEGE OF MEDICAL TOXICOLOGY · PI KOSNETT, MICHAEL J · 2009 to 2013
$587k
ATSDR CDC HHS 1U61TS000117-04ATSDR CDC HHS U61 TS000117Intramural NIH HHS
6 · The paper itself

Abstract

Lead exposure in children is one component leading to cognitive impairment. The Treatment of Lead-Exposed Children Trial (1994-2004) studied the effect of succimer in treating low levels of lead exposure (20-44 mcg/dL) in children 12 to 33 months old. While succimer was effective in reducing blood lead concentrations in the short term, treatment of blood lead levels did not result in any detectable improvement in a wide variety of measurements of cognitive or behavioral function. Furthermore, blood lead concentrations were not distinguishable between chelated and non-chelated individuals at 1 year. The most important treatment strategy is identification and termination of major sources of lead exposure.

Indexed as

Chelation TherapyAge FactorsBiomarkersChelating AgentsChildChild, PreschoolCognitionEnvironmental ExposureFemaleHumansInfantInfant BehaviorLeadLead Poisoning, Nervous System, ChildhoodMaleRandomized Controlled Trials as TopicBiomarkersChelating AgentsLeadSuccimer

Identifiers

PMID24178899
PMCPMC3846968
OpenAlexW2028836441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.